Skip to content

S-ketamine and cesarean section postoperative pain

S-Ketamine combined Anesthesia in improving the Analgesia effect of Cesarean Section: a randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078310
Enrollment
Unknown
Registered
2023-12-05
Start date
2023-12-05
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section postoperative pain

Interventions

Group E:Immediately after severing the umbilical cord, S-ketamine hydrochloride injection 0.5mg/Kg was injected intravenously, and the administration time was limited to 60 ±10 seconds. At the end of
Group C:Immediately after the umbilical cord was severed, the same amount of normal saline was given to S-ketamine hydrochloride injection. After the operation, the patient-controlled intravenous anal

Sponsors

Fuling Hospital Affiliated to Chongqing University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) 20-45 years old; (2) Single pregnant women who underwent cesarean section under elective spinal anesthesia (3) ASA II-III (4) Voluntarily participated in the study and signed the informed consent

Exclusion criteria

Exclusion criteria: (1) parturients with contraindications for cesarean section, such as intrauterine stillbirth, fetal malformation, maternal intolerance to surgery, fetal distress, etc.; (2) parturients with contraindications to intraspinal anesthesia such as coagulation dysfunction and central system diseases; (3) parturients with contraindications to esketamine, such as hyperthyroidism, severe hypertension, preeclampsia, mental disorders, need to relax the uterus, such as umbilical cord prolapse and uterine rupture. (4) pregnant women who were addicted to alcohol and took opioids, hormones and anti-inflammatory and analgesic drugs for a long time; (5)parturients were allergic to the drugs used in the trial; and (6)those who could not cooperate with the study or refused to participate in the study.

Design outcomes

Primary

MeasureTime frame
maxmum pain NRS score 24h postoperatively;

Secondary

MeasureTime frame
Pressure pain threshold;Pressure pain tolerance;Serum C-reactive protein concentration;The time of patient-controlled analgesia for the first time after operation;Number of compressions of patient-controlled analgesia;Patient-controlled analgesia pump drug dosage;Dosage of Tramadol;Incidence of anxiety;Incidence of depression;Incidence of sleep disorders;Incidence of side effects of S-ketamine;

Countries

China

Contacts

Public ContactJunhua Zhang

Fuling Hospital Affiliated to Chongqing University

272073444@qq.com+86 152 1368 0591

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026